Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancerDouglas G McNeel, Edward J Dunphy, James G Davies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2009
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II studyAnne M Traynor, Sarita Dubey, Jens C Eickhoff, et al.
Investigational New Drugs|December 16, 2015
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancerDustin A Deming, Ludmila L Cavalcante, Sam J Lubner, et al.
Journal of Surgical Oncology|January 6, 2025
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction CancerNataliya V Uboha, Mustafa M Basree, Jens C Eickhoff, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2020
Orosomucoid-like 3 Supports Rhinovirus Replication in Human Epithelial CellsYiping Liu, Yury A Bochkov, Jens C Eickhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b TrialMichael F Bassetti, Brett A Morris, Nan Sethakorn, et al.
Science Advances|June 4, 2025
Low-dose radiation by radiopharmaceutical therapy enhances GD2 TRAC-CAR T cell efficacy in localized neuroblastomaQuaovi H Sodji, Amanda Shea, Dan Cappabianca, et al.
Cancers|January 11, 2024
Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and FunctionsQuaovi H Sodji, Matthew H Forsberg, Dan Cappabianca, et al.
Oncogene|May 10, 2016
FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphomaY Li, M N Bouchlaka, J Wolff, et al.
British Journal of Haematology|August 19, 2011
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network studyJulie E Chang, Christopher Peterson, Sangbum Choi, et al.
Pageof 23